Oxford Asset Management’s Revance Therapeutics, Inc. RVNC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-54,923
| Closed | -$285K | – | 611 |
|
|
2024
Q3 | $285K | Buy |
+54,923
| New | +$285K | 0.24% | 169 |
|
|
2020
Q1 | – | Sell |
-21,082
| Closed | -$342K | – | 1388 |
|
|
2019
Q4 | $342K | Buy |
+21,082
| New | +$342K | 0.01% | 1389 |
|
|
2019
Q2 | – | Sell |
-35,199
| Closed | -$555K | – | 1999 |
|
|
2019
Q1 | $555K | Sell |
35,199
-3,848
| -10% | -$60.7K | 0.01% | 1168 |
|
|
2018
Q4 | $786K | Buy |
+39,047
| New | +$786K | 0.02% | 977 |
|
|
2018
Q2 | – | Sell |
-28,063
| Closed | -$864K | – | 1969 |
|
|
2018
Q1 | $864K | Buy |
+28,063
| New | +$864K | 0.02% | 1001 |
|
|
2016
Q1 | – | Sell |
-57,641
| Closed | -$1.99M | – | 913 |
|
|
2015
Q4 | $1.99M | Buy |
+57,641
| New | +$1.99M | 0.05% | 396 |
|